春立医疗2025年业绩快报：归母净利润同比增长117.72%

Core Viewpoint - The company reported significant growth in both revenue and net profit for the fiscal year 2025, indicating strong operational performance and effective management strategies [1] Financial Performance - The company achieved total revenue of 1.044 billion yuan, representing a year-on-year increase of 29.52% [1] - The net profit attributable to shareholders reached 272 million yuan, marking a substantial year-on-year growth of 117.72% [1] - As of the end of the reporting period, total assets amounted to 3.659 billion yuan, reflecting a growth of 5.58% compared to the beginning of the period [1] Business Development - The company's product collection and procurement have led to a sustained release of growth potential [1] - International business operations are progressing steadily, contributing to revenue growth [1] - The company continues to optimize operational management and resource allocation, enhancing operational efficiency and profitability [1]